InvestorsHub Logo
Followers 62
Posts 7557
Boards Moderated 1
Alias Born 01/02/2003

Re: JRoon71 post# 393860

Thursday, 11/17/2022 11:47:20 AM

Thursday, November 17, 2022 11:47:20 AM

Post# of 426487
If there is any chance of Amarin issuing a FDC drug (with statin plus MND-2119), we need to hear details about it NOW...before Amarin stock price drops still further!...The patented gelatin capsule will apparently not be coming to the rescue of Vascepa ...Something more is needed...and the good news is that it is available from this combo drug.

This new patented drug is Amarin's main opportunity to take itself out of the doldrums and redeem itself, recapturing the AMERICAN market with a superior and less expensive formulation of EPA.

Its a pity that Amarin management did not embark upon a pursuit of this new drug long ago when Craig Granowitz was chief of R and D.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News